Product Information
DESCOVY 200-25 MG TABLET is a brand product labeled by Gilead Sciences, Inc., priced at $71.4409 per EA under NDC 61958200202. Its NADAC has been published 329 times since Mar 11, 2020.
Strength
200; 25 mg/1; mg/1
Manufacturer
Gilead Sciences, Inc.NDC
61958200202
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA208215On Market Since
4/4/2016
Pharmacological Classes
Price Statistics
The NADAC for DESCOVY 200-25 MG TABLET has been published 329 times since Mar 11, 2020, and over the history we have for it it has risen 19.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $71.4409 per EA |
|---|---|
| All-time high | $71.4409 (Jun 24, 2026) |
| All-time low | $59.6679 (Oct 21, 2020) |
| 52-week high | $71.4409 |
| 52-week low | $71.2856 |
| Median price | $70.0275 |
| Average price | $67.3601 |
| Largest weekly change | +5.9% (Jan 11, 2023) |
| Weeks tracked | 329 |
| Tracking since | Mar 11, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DESCOVY 200-25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DESCOVY 200-25 MG TABLET, manufactured by Gilead Sciences, Inc., is $71.4409 per EA (NDC 61958200202), effective Jun 24, 2026.
How has the price of DESCOVY 200-25 MG TABLET changed over time?
Over the history we have for it, the NADAC for DESCOVY 200-25 MG TABLET has risen 19.7%. It has been tracked across 329 weekly CMS publications since Mar 11, 2020.
What are the highest and lowest recorded NADAC prices for DESCOVY 200-25 MG TABLET?
Since Mar 11, 2020, the NADAC for DESCOVY 200-25 MG TABLET has ranged from a low of $59.6679 (Oct 21, 2020) to a high of $71.4409 (Jun 24, 2026), with a median of $70.0275 per EA.
Are there cheaper alternatives to DESCOVY 200-25 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DESCOVY 200-25 MG TABLET, but none are currently priced below it.
Who manufactures DESCOVY 200-25 MG TABLET?
DESCOVY 200-25 MG TABLET (NDC 61958200202) is labeled by Gilead Sciences, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification